No easy answers for chemotherapy‐induced peripheral neuropathy

Neuropathy is a challenging long-term side-effect of weekly paclitaxel administration –  the most commonly used regime for adjuvant treatment of early breast cancer, Australian research has shown. More than half of women who started on a course of paclitaxel reported numbness and tingling after six weeks, and the neuropathy persisted at 12 months, a NSW study ...